 | • レポートコード：GIR-107A12162 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、舞踏病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。舞踏病治療の種類別市場規模（医療、外科療法）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・舞踏病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Medtronic、Boston Scientific、Aleva Neurotherapeutics、Teva Pharmaceutical、Pfizer、GlaxoSmithKline、Bausch Health Companies、LivaNova、Lundbeck、Ipsen、Alnylam Pharmaceuticals、Prana Biotechnology、RespireRx Pharmaceuticals、Vertex Pharmaceuticals、SOM Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：医療、外科療法 ・用途別分析2016年-2026年：病院、クリニック、その他 ・舞踏病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・舞踏病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・舞踏病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・舞踏病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・舞踏病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chorea Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chorea Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Chorea Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chorea Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Medication
Surgery Therapy
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Chorea Treatment
1.2 Classification of Chorea Treatment by Type
1.2.1 Overview: Global Chorea Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Chorea Treatment Revenue Market Share by Type in 2020
1.2.3 Medication
1.2.4 Surgery Therapy
1.3 Global Chorea Treatment Market by Application
1.3.1 Overview: Global Chorea Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Chorea Treatment Market Size & Forecast
1.5 Global Chorea Treatment Market Size and Forecast by Region
1.5.1 Global Chorea Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Chorea Treatment Market Size by Region, (2016-2021)
1.5.3 North America Chorea Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Chorea Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Chorea Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Chorea Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Chorea Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Chorea Treatment Market Drivers
1.6.2 Chorea Treatment Market Restraints
1.6.3 Chorea Treatment Trends Analysis
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Chorea Treatment Product and Solutions
2.1.4 Medtronic Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Chorea Treatment Product and Solutions
2.2.4 Boston Scientific Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boston Scientific Recent Developments and Future Plans
2.3 Aleva Neurotherapeutics
2.3.1 Aleva Neurotherapeutics Details
2.3.2 Aleva Neurotherapeutics Major Business
2.3.3 Aleva Neurotherapeutics Chorea Treatment Product and Solutions
2.3.4 Aleva Neurotherapeutics Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Aleva Neurotherapeutics Recent Developments and Future Plans
2.4 Teva Pharmaceutical
2.4.1 Teva Pharmaceutical Details
2.4.2 Teva Pharmaceutical Major Business
2.4.3 Teva Pharmaceutical Chorea Treatment Product and Solutions
2.4.4 Teva Pharmaceutical Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Teva Pharmaceutical Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Chorea Treatment Product and Solutions
2.5.4 Pfizer Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Chorea Treatment Product and Solutions
2.6.4 GlaxoSmithKline Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Bausch Health Companies
2.7.1 Bausch Health Companies Details
2.7.2 Bausch Health Companies Major Business
2.7.3 Bausch Health Companies Chorea Treatment Product and Solutions
2.7.4 Bausch Health Companies Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bausch Health Companies Recent Developments and Future Plans
2.8 LivaNova
2.8.1 LivaNova Details
2.8.2 LivaNova Major Business
2.8.3 LivaNova Chorea Treatment Product and Solutions
2.8.4 LivaNova Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 LivaNova Recent Developments and Future Plans
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Chorea Treatment Product and Solutions
2.9.4 Lundbeck Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Lundbeck Recent Developments and Future Plans
2.10 Ipsen
2.10.1 Ipsen Details
2.10.2 Ipsen Major Business
2.10.3 Ipsen Chorea Treatment Product and Solutions
2.10.4 Ipsen Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Ipsen Recent Developments and Future Plans
2.11 Alnylam Pharmaceuticals
2.11.1 Alnylam Pharmaceuticals Details
2.11.2 Alnylam Pharmaceuticals Major Business
2.11.3 Alnylam Pharmaceuticals Chorea Treatment Product and Solutions
2.11.4 Alnylam Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.12 Prana Biotechnology
2.12.1 Prana Biotechnology Details
2.12.2 Prana Biotechnology Major Business
2.12.3 Prana Biotechnology Chorea Treatment Product and Solutions
2.12.4 Prana Biotechnology Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Prana Biotechnology Recent Developments and Future Plans
2.13 RespireRx Pharmaceuticals
2.13.1 RespireRx Pharmaceuticals Details
2.13.2 RespireRx Pharmaceuticals Major Business
2.13.3 RespireRx Pharmaceuticals Chorea Treatment Product and Solutions
2.13.4 RespireRx Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 RespireRx Pharmaceuticals Recent Developments and Future Plans
2.14 Vertex Pharmaceuticals
2.14.1 Vertex Pharmaceuticals Details
2.14.2 Vertex Pharmaceuticals Major Business
2.14.3 Vertex Pharmaceuticals Chorea Treatment Product and Solutions
2.14.4 Vertex Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Vertex Pharmaceuticals Recent Developments and Future Plans
2.15 SOM Biotech
2.15.1 SOM Biotech Details
2.15.2 SOM Biotech Major Business
2.15.3 SOM Biotech Chorea Treatment Product and Solutions
2.15.4 SOM Biotech Chorea Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 SOM Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Chorea Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Chorea Treatment Players Market Share
3.2.2 Top 10 Chorea Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Chorea Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Chorea Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Chorea Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Chorea Treatment Revenue Market Share by Application (2016-2021)
5.2 Chorea Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Chorea Treatment Revenue by Type (2016-2026)
6.2 North America Chorea Treatment Revenue by Application (2016-2026)
6.3 North America Chorea Treatment Market Size by Country
6.3.1 North America Chorea Treatment Revenue by Country (2016-2026)
6.3.2 United States Chorea Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Chorea Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Chorea Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Chorea Treatment Revenue by Type (2016-2026)
7.2 Europe Chorea Treatment Revenue by Application (2016-2026)
7.3 Europe Chorea Treatment Market Size by Country
7.3.1 Europe Chorea Treatment Revenue by Country (2016-2026)
7.3.2 Germany Chorea Treatment Market Size and Forecast (2016-2026)
7.3.3 France Chorea Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Chorea Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Chorea Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Chorea Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Chorea Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Chorea Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Chorea Treatment Market Size by Region
8.3.1 Asia-Pacific Chorea Treatment Revenue by Region (2016-2026)
8.3.2 China Chorea Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Chorea Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Chorea Treatment Market Size and Forecast (2016-2026)
8.3.5 India Chorea Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Chorea Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Chorea Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Chorea Treatment Revenue by Type (2016-2026)
9.2 South America Chorea Treatment Revenue by Application (2016-2026)
9.3 South America Chorea Treatment Market Size by Country
9.3.1 South America Chorea Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Chorea Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Chorea Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Chorea Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Chorea Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Chorea Treatment Market Size by Country
10.3.1 Middle East & Africa Chorea Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Chorea Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Chorea Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Chorea Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Chorea Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Chorea Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Chorea Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Chorea Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Chorea Treatment Revenue Market Share by Region (2021-2026)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Chorea Treatment Product and Solutions
Table 9. Medtronic Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Boston Scientific Major Business
Table 12. Boston Scientific Chorea Treatment Product and Solutions
Table 13. Boston Scientific Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Aleva Neurotherapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Aleva Neurotherapeutics Major Business
Table 16. Aleva Neurotherapeutics Chorea Treatment Product and Solutions
Table 17. Aleva Neurotherapeutics Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Teva Pharmaceutical Major Business
Table 20. Teva Pharmaceutical Chorea Treatment Product and Solutions
Table 21. Teva Pharmaceutical Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Chorea Treatment Product and Solutions
Table 25. Pfizer Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Major Business
Table 28. GlaxoSmithKline Chorea Treatment Product and Solutions
Table 29. GlaxoSmithKline Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bausch Health Companies Corporate Information, Head Office, and Major Competitors
Table 31. Bausch Health Companies Major Business
Table 32. Bausch Health Companies Chorea Treatment Product and Solutions
Table 33. Bausch Health Companies Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. LivaNova Corporate Information, Head Office, and Major Competitors
Table 35. LivaNova Major Business
Table 36. LivaNova Chorea Treatment Product and Solutions
Table 37. LivaNova Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Lundbeck Corporate Information, Head Office, and Major Competitors
Table 39. Lundbeck Major Business
Table 40. Lundbeck Chorea Treatment Product and Solutions
Table 41. Lundbeck Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Ipsen Corporate Information, Head Office, and Major Competitors
Table 43. Ipsen Major Business
Table 44. Ipsen Chorea Treatment Product and Solutions
Table 45. Ipsen Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Alnylam Pharmaceuticals Major Business
Table 48. Alnylam Pharmaceuticals Chorea Treatment Product and Solutions
Table 49. Alnylam Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Prana Biotechnology Corporate Information, Head Office, and Major Competitors
Table 51. Prana Biotechnology Major Business
Table 52. Prana Biotechnology Chorea Treatment Product and Solutions
Table 53. Prana Biotechnology Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. RespireRx Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. RespireRx Pharmaceuticals Major Business
Table 56. RespireRx Pharmaceuticals Chorea Treatment Product and Solutions
Table 57. RespireRx Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Vertex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Vertex Pharmaceuticals Major Business
Table 60. Vertex Pharmaceuticals Chorea Treatment Product and Solutions
Table 61. Vertex Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. SOM Biotech Corporate Information, Head Office, and Major Competitors
Table 63. SOM Biotech Major Business
Table 64. SOM Biotech Chorea Treatment Product and Solutions
Table 65. SOM Biotech Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Chorea Treatment Revenue (USD Million) by Players (2019-2021)
Table 67. Global Chorea Treatment Revenue Share by Players (2019-2021)
Table 68. Breakdown of Chorea Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Chorea Treatment Players Head Office, Products and Services Provided
Table 70. Chorea Treatment Mergers & Acquisitions in the Past Five Years
Table 71. Chorea Treatment New Entrants and Expansion Plans
Table 72. Global Chorea Treatment Revenue (USD Million) by Type (2016-2021)
Table 73. Global Chorea Treatment Revenue Share by Type (2016-2021)
Table 74. Global Chorea Treatment Revenue Forecast by Type (2021-2026)
Table 75. Global Chorea Treatment Revenue by Application (2016-2021)
Table 76. Global Chorea Treatment Revenue Forecast by Application (2021-2026)
Table 77. North America Chorea Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Chorea Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Chorea Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Chorea Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Chorea Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Chorea Treatment Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Chorea Treatment Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Chorea Treatment Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Chorea Treatment Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Chorea Treatment Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Chorea Treatment Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Chorea Treatment Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Chorea Treatment Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Chorea Treatment Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Chorea Treatment Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Chorea Treatment Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Chorea Treatment Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Chorea Treatment Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Chorea Treatment Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Chorea Treatment Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Chorea Treatment Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Chorea Treatment Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Chorea Treatment Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Chorea Treatment Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Chorea Treatment Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Chorea Treatment Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Chorea Treatment Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Chorea Treatment Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Chorea Treatment Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Chorea Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Chorea Treatment Picture
Figure 2. Global Chorea Treatment Revenue Market Share by Type in 2020
Figure 3. Medication
Figure 4. Surgery Therapy
Figure 5. Chorea Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Chorea Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Chorea Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Chorea Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Chorea Treatment Revenue Market Share by Region in 2020
Figure 13. North America Chorea Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Chorea Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Chorea Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Chorea Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Chorea Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Chorea Treatment Market Drivers
Figure 19. Chorea Treatment Market Restraints
Figure 20. Chorea Treatment Market Trends
Figure 21. Medtronic Recent Developments and Future Plans
Figure 22. Boston Scientific Recent Developments and Future Plans
Figure 23. Aleva Neurotherapeutics Recent Developments and Future Plans
Figure 24. Teva Pharmaceutical Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. Bausch Health Companies Recent Developments and Future Plans
Figure 28. LivaNova Recent Developments and Future Plans
Figure 29. Lundbeck Recent Developments and Future Plans
Figure 30. Ipsen Recent Developments and Future Plans
Figure 31. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 32. Prana Biotechnology Recent Developments and Future Plans
Figure 33. RespireRx Pharmaceuticals Recent Developments and Future Plans
Figure 34. Vertex Pharmaceuticals Recent Developments and Future Plans
Figure 35. SOM Biotech Recent Developments and Future Plans
Figure 36. Global Chorea Treatment Revenue Share by Players in 2020
Figure 37. Chorea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Chorea Treatment Revenue Market Share in 2020
Figure 39. Global Top 10 Players Chorea Treatment Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Chorea Treatment Revenue Share by Type in 2020
Figure 42. Global Chorea Treatment Market Share Forecast by Type (2021-2026)
Figure 43. Global Chorea Treatment Revenue Share by Application in 2020
Figure 44. Global Chorea Treatment Market Share Forecast by Application (2021-2026)
Figure 45. North America Chorea Treatment Sales Market Share by Type (2016-2026)
Figure 46. North America Chorea Treatment Sales Market Share by Application (2016-2026)
Figure 47. North America Chorea Treatment Revenue Market Share by Country (2016-2026)
Figure 48. United States Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Chorea Treatment Sales Market Share by Type (2016-2026)
Figure 52. Europe Chorea Treatment Sales Market Share by Application (2016-2026)
Figure 53. Europe Chorea Treatment Revenue Market Share by Country (2016-2026)
Figure 54. Germany Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Chorea Treatment Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Chorea Treatment Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Chorea Treatment Revenue Market Share by Region (2016-2026)
Figure 62. China Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Chorea Treatment Sales Market Share by Type (2016-2026)
Figure 69. South America Chorea Treatment Sales Market Share by Application (2016-2026)
Figure 70. South America Chorea Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Chorea Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Chorea Treatment Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Chorea Treatment Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Chorea Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の舞踏病治療市場予測（～2024年） Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disor…- 世界のダンピング症候群治療市場 2021：企業別、地域別、種類・用途別 The Dumping Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の脳性麻痺治療市場 2021：企業別、地域別、種類・用途別 The Cerebral Palsy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のQT延長症候群治療市場 2021：企業別、地域別、種類・用途別 The Long QT Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の坐骨神経痛治療市場 2021：企業別、地域別、種類・用途別 The Sciatica Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…